Characterization of in vitro and in vivo hypomethylating effects of decitabine in acute myeloid leukemia by a rapid, specific and sensitive LC-MS/MS method

DNA hypermethylation is a common finding in malignant cells and has been explored as a therapeutic target for hypomethylating agents (e.g., decitabine). Detection of changes in DNA methylation might serve as a pharmacodynamic endpoint to establish the biological activity of these agents and predict...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Zhongfa, Liu, Shujun, Xie, Zhiliang, Blum, William, Perrotti, Danilo, Paschka, Peter, Klisovic, Rebecca, Byrd, John, Chan, Kenneth K., Marcucci, Guido
Formato: Texto
Lenguaje:English
Publicado: Oxford University Press 2007
Materias:
Methods Online
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1865075/
https://www.ncbi.nlm.nih.gov/pubmed/17264127
http://dx.doi.org/10.1093/nar/gkl1156

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1865075/
https://www.ncbi.nlm.nih.gov/pubmed/17264127
http://dx.doi.org/10.1093/nar/gkl1156

Ejemplares similares